nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Alkylating Activity—Temozolomide—malignant glioma	0.588	1	CiPCiCtD
Carmustine—brain cancer—malignant glioma	0.369	1	CtDrD
Carmustine—Edema cerebral—Temozolomide—malignant glioma	0.00211	0.0833	CcSEcCtD
Carmustine—GSR—Glutathione metabolism—IDH1—malignant glioma	0.00135	0.102	CbGpPWpGaD
Carmustine—Infertility—Temozolomide—malignant glioma	0.00125	0.0493	CcSEcCtD
Carmustine—Brain oedema—Temozolomide—malignant glioma	0.00114	0.0451	CcSEcCtD
Carmustine—Acute leukaemia—Temozolomide—malignant glioma	0.00114	0.0451	CcSEcCtD
Carmustine—Hemiplegia—Temozolomide—malignant glioma	0.000914	0.0361	CcSEcCtD
Carmustine—Pulmonary fibrosis—Temozolomide—malignant glioma	0.000742	0.0293	CcSEcCtD
Carmustine—GSR—embryo—malignant glioma	0.000698	0.165	CbGeAlD
Carmustine—Myelosuppression—Temozolomide—malignant glioma	0.000696	0.0275	CcSEcCtD
Carmustine—Faecal incontinence—Temozolomide—malignant glioma	0.000647	0.0255	CcSEcCtD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—SOD1—malignant glioma	0.000646	0.049	CbGpPWpGaD
Carmustine—GSR—brainstem—malignant glioma	0.00064	0.152	CbGeAlD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—GSTP1—malignant glioma	0.00063	0.0479	CbGpPWpGaD
Carmustine—GSR—retina—malignant glioma	0.000617	0.146	CbGeAlD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—CAT—malignant glioma	0.000613	0.0466	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—SOD1—malignant glioma	0.000593	0.0451	CbGpPWpGaD
Carmustine—Cerebral haemorrhage—Temozolomide—malignant glioma	0.000589	0.0233	CcSEcCtD
Carmustine—GSR—telencephalon—malignant glioma	0.000568	0.134	CbGeAlD
Carmustine—GSR—Oxidative Stress—CAT—malignant glioma	0.000564	0.0428	CbGpPWpGaD
Carmustine—Febrile neutropenia—Temozolomide—malignant glioma	0.000542	0.0214	CcSEcCtD
Carmustine—Oral candidiasis—Temozolomide—malignant glioma	0.000514	0.0203	CcSEcCtD
Carmustine—GSR—NRF2 pathway—FTH1—malignant glioma	0.000507	0.0385	CbGpPWpGaD
Carmustine—Aphasia—Temozolomide—malignant glioma	0.000503	0.0199	CcSEcCtD
Carmustine—Interstitial lung disease—Temozolomide—malignant glioma	0.000461	0.0182	CcSEcCtD
Carmustine—Scotoma—Temozolomide—malignant glioma	0.00043	0.017	CcSEcCtD
Carmustine—Hepatotoxicity—Temozolomide—malignant glioma	0.000423	0.0167	CcSEcCtD
Carmustine—GSR—midbrain—malignant glioma	0.000408	0.0966	CbGeAlD
Carmustine—GSR—spinal cord—malignant glioma	0.000398	0.0942	CbGeAlD
Carmustine—Speech disorder—Temozolomide—malignant glioma	0.000379	0.015	CcSEcCtD
Carmustine—Gait disturbance—Temozolomide—malignant glioma	0.000334	0.0132	CcSEcCtD
Carmustine—Coordination abnormal—Temozolomide—malignant glioma	0.000332	0.0131	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000331	0.0251	CbGpPWpGaD
Carmustine—Pulmonary embolism—Temozolomide—malignant glioma	0.000326	0.0129	CcSEcCtD
Carmustine—GSR—central nervous system—malignant glioma	0.000323	0.0764	CbGeAlD
Carmustine—GSR—cerebellum—malignant glioma	0.000316	0.0747	CbGeAlD
Carmustine—Urinary incontinence—Temozolomide—malignant glioma	0.000315	0.0124	CcSEcCtD
Carmustine—Depressed level of consciousness—Temozolomide—malignant glioma	0.000315	0.0124	CcSEcCtD
Carmustine—Candida infection—Temozolomide—malignant glioma	0.000312	0.0123	CcSEcCtD
Carmustine—Skin exfoliation—Temozolomide—malignant glioma	0.000312	0.0123	CcSEcCtD
Carmustine—Neuropathy—Temozolomide—malignant glioma	0.000306	0.0121	CcSEcCtD
Carmustine—Neoplasm—Temozolomide—malignant glioma	0.000295	0.0116	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—CYP2B6—malignant glioma	0.000291	0.0221	CbGpPWpGaD
Carmustine—Abnormal vision—Temozolomide—malignant glioma	0.000285	0.0112	CcSEcCtD
Carmustine—Mental disability—Temozolomide—malignant glioma	0.000283	0.0112	CcSEcCtD
Carmustine—Thrombophlebitis—Temozolomide—malignant glioma	0.000274	0.0108	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—BMI1—malignant glioma	0.000269	0.0204	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—CAT—malignant glioma	0.000262	0.0199	CbGpPWpGaD
Carmustine—Eye pain—Temozolomide—malignant glioma	0.000262	0.0104	CcSEcCtD
Carmustine—GSR—brain—malignant glioma	0.000256	0.0607	CbGeAlD
Carmustine—Amnesia—Temozolomide—malignant glioma	0.000252	0.00995	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—CYP2C18—malignant glioma	0.000252	0.0191	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SOD1—malignant glioma	0.000251	0.0191	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—POR—malignant glioma	0.000239	0.0181	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—CAT—malignant glioma	0.000238	0.0181	CbGpPWpGaD
Carmustine—Diplopia—Temozolomide—malignant glioma	0.000237	0.00935	CcSEcCtD
Carmustine—Face oedema—Temozolomide—malignant glioma	0.000229	0.00903	CcSEcCtD
Carmustine—Ataxia—Temozolomide—malignant glioma	0.000223	0.00879	CcSEcCtD
Carmustine—Hypokalaemia—Temozolomide—malignant glioma	0.000216	0.00851	CcSEcCtD
Carmustine—Muscular weakness—Temozolomide—malignant glioma	0.000209	0.00825	CcSEcCtD
Carmustine—Dysphagia—Temozolomide—malignant glioma	0.000205	0.00808	CcSEcCtD
Carmustine—CYP1A2—Xenobiotics—CYP2B6—malignant glioma	0.000203	0.0154	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC5A5—malignant glioma	0.000203	0.0154	CbGpPWpGaD
Carmustine—Pancytopenia—Temozolomide—malignant glioma	0.000194	0.00767	CcSEcCtD
Carmustine—GSR—NRF2 pathway—SLC6A3—malignant glioma	0.000193	0.0147	CbGpPWpGaD
Carmustine—Neutropenia—Temozolomide—malignant glioma	0.000191	0.00756	CcSEcCtD
Carmustine—Hyperglycaemia—Temozolomide—malignant glioma	0.000185	0.00729	CcSEcCtD
Carmustine—Pneumonia—Temozolomide—malignant glioma	0.000184	0.00725	CcSEcCtD
Carmustine—Depression—Temozolomide—malignant glioma	0.000182	0.00718	CcSEcCtD
Carmustine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000179	0.00706	CcSEcCtD
Carmustine—Stomatitis—Temozolomide—malignant glioma	0.000178	0.00702	CcSEcCtD
Carmustine—Urinary tract infection—Temozolomide—malignant glioma	0.000177	0.007	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—HIST1H3B—malignant glioma	0.000176	0.0134	CbGpPWpGaD
Carmustine—CYP1A2—Xenobiotics—CYP2C18—malignant glioma	0.000176	0.0134	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—F2—malignant glioma	0.000175	0.0133	CbGpPWpGaD
Carmustine—Haemoglobin—Temozolomide—malignant glioma	0.000165	0.0065	CcSEcCtD
Carmustine—Haemorrhage—Temozolomide—malignant glioma	0.000164	0.00647	CcSEcCtD
Carmustine—GSR—NRF2 pathway—GSTP1—malignant glioma	0.000163	0.0124	CbGpPWpGaD
Carmustine—Hallucination—Temozolomide—malignant glioma	0.000163	0.00644	CcSEcCtD
Carmustine—Hypoaesthesia—Temozolomide—malignant glioma	0.000163	0.00644	CcSEcCtD
Carmustine—Oedema peripheral—Temozolomide—malignant glioma	0.000161	0.00637	CcSEcCtD
Carmustine—Connective tissue disorder—Temozolomide—malignant glioma	0.000161	0.00636	CcSEcCtD
Carmustine—Visual impairment—Temozolomide—malignant glioma	0.000158	0.00623	CcSEcCtD
Carmustine—Eye disorder—Temozolomide—malignant glioma	0.000153	0.00604	CcSEcCtD
Carmustine—Flushing—Temozolomide—malignant glioma	0.000152	0.006	CcSEcCtD
Carmustine—CYP1A2—Tryptophan metabolism—ASMT—malignant glioma	0.000146	0.0111	CbGpPWpGaD
Carmustine—GSR—Metabolism—RTEL1—malignant glioma	0.000145	0.011	CbGpPWpGaD
Carmustine—Alopecia—Temozolomide—malignant glioma	0.000145	0.00572	CcSEcCtD
Carmustine—Mental disorder—Temozolomide—malignant glioma	0.000144	0.00567	CcSEcCtD
Carmustine—Malnutrition—Temozolomide—malignant glioma	0.000143	0.00563	CcSEcCtD
Carmustine—Erythema—Temozolomide—malignant glioma	0.000143	0.00563	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—GSTP1—malignant glioma	0.000141	0.0107	CbGpPWpGaD
Carmustine—Back pain—Temozolomide—malignant glioma	0.000138	0.00545	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—H3F3A—malignant glioma	0.000136	0.0103	CbGpPWpGaD
Carmustine—Vision blurred—Temozolomide—malignant glioma	0.000134	0.00531	CcSEcCtD
Carmustine—Tremor—Temozolomide—malignant glioma	0.000134	0.00528	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000133	0.0101	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—IFNG—malignant glioma	0.000132	0.0101	CbGpPWpGaD
Carmustine—Anaemia—Temozolomide—malignant glioma	0.000132	0.0052	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—YWHAE—malignant glioma	0.000131	0.00996	CbGpPWpGaD
Carmustine—Agitation—Temozolomide—malignant glioma	0.000131	0.00517	CcSEcCtD
Carmustine—GSR—NRF2 pathway—PDGFB—malignant glioma	0.000129	0.00981	CbGpPWpGaD
Carmustine—Leukopenia—Temozolomide—malignant glioma	0.000128	0.00504	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000127	0.00964	CbGpPWpGaD
Carmustine—Convulsion—Temozolomide—malignant glioma	0.000124	0.00488	CcSEcCtD
Carmustine—Hypertension—Temozolomide—malignant glioma	0.000123	0.00486	CcSEcCtD
Carmustine—Myalgia—Temozolomide—malignant glioma	0.000121	0.00479	CcSEcCtD
Carmustine—Anxiety—Temozolomide—malignant glioma	0.000121	0.00478	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—IL1B—malignant glioma	0.000118	0.00896	CbGpPWpGaD
Carmustine—Confusional state—Temozolomide—malignant glioma	0.000117	0.00463	CcSEcCtD
Carmustine—Oedema—Temozolomide—malignant glioma	0.000116	0.0046	CcSEcCtD
Carmustine—Infection—Temozolomide—malignant glioma	0.000116	0.00457	CcSEcCtD
Carmustine—Thrombocytopenia—Temozolomide—malignant glioma	0.000114	0.0045	CcSEcCtD
Carmustine—Anorexia—Temozolomide—malignant glioma	0.000111	0.00438	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000106	0.00419	CcSEcCtD
Carmustine—Insomnia—Temozolomide—malignant glioma	0.000105	0.00416	CcSEcCtD
Carmustine—Paraesthesia—Temozolomide—malignant glioma	0.000105	0.00413	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—SOD1—malignant glioma	0.000104	0.00791	CbGpPWpGaD
Carmustine—Dyspnoea—Temozolomide—malignant glioma	0.000104	0.0041	CcSEcCtD
Carmustine—Somnolence—Temozolomide—malignant glioma	0.000104	0.00409	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—GSTP1—malignant glioma	0.000102	0.00772	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.000101	0.0077	CbGpPWpGaD
Carmustine—Decreased appetite—Temozolomide—malignant glioma	0.000101	0.00399	CcSEcCtD
Carmustine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000101	0.00397	CcSEcCtD
Carmustine—Constipation—Temozolomide—malignant glioma	9.96e-05	0.00393	CcSEcCtD
Carmustine—Pain—Temozolomide—malignant glioma	9.96e-05	0.00393	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CAT—malignant glioma	9.9e-05	0.00752	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN2B—malignant glioma	9.85e-05	0.00748	CbGpPWpGaD
Carmustine—Feeling abnormal—Temozolomide—malignant glioma	9.59e-05	0.00379	CcSEcCtD
Carmustine—Gastrointestinal pain—Temozolomide—malignant glioma	9.52e-05	0.00376	CcSEcCtD
Carmustine—Body temperature increased—Temozolomide—malignant glioma	9.2e-05	0.00363	CcSEcCtD
Carmustine—Abdominal pain—Temozolomide—malignant glioma	9.2e-05	0.00363	CcSEcCtD
Carmustine—CYP1A2—Tryptophan metabolism—CYP2C18—malignant glioma	9.03e-05	0.00686	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	9.03e-05	0.00686	CbGpPWpGaD
Carmustine—Hypersensitivity—Temozolomide—malignant glioma	8.58e-05	0.00339	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—TNF—malignant glioma	8.57e-05	0.0065	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	8.42e-05	0.0064	CbGpPWpGaD
Carmustine—Asthenia—Temozolomide—malignant glioma	8.35e-05	0.0033	CcSEcCtD
Carmustine—GSR—Metabolism—COX8A—malignant glioma	8.32e-05	0.00632	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	8.31e-05	0.00631	CbGpPWpGaD
Carmustine—Diarrhoea—Temozolomide—malignant glioma	7.97e-05	0.00314	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—HIF1A—malignant glioma	7.88e-05	0.00598	CbGpPWpGaD
Carmustine—Dizziness—Temozolomide—malignant glioma	7.7e-05	0.00304	CcSEcCtD
Carmustine—Vomiting—Temozolomide—malignant glioma	7.4e-05	0.00292	CcSEcCtD
Carmustine—Rash—Temozolomide—malignant glioma	7.34e-05	0.0029	CcSEcCtD
Carmustine—Dermatitis—Temozolomide—malignant glioma	7.33e-05	0.00289	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	7.3e-05	0.00555	CbGpPWpGaD
Carmustine—Headache—Temozolomide—malignant glioma	7.29e-05	0.00288	CcSEcCtD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	7.21e-05	0.00547	CbGpPWpGaD
Carmustine—GSR—Metabolism—ASMT—malignant glioma	7.07e-05	0.00537	CbGpPWpGaD
Carmustine—Nausea—Temozolomide—malignant glioma	6.92e-05	0.00273	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	6.83e-05	0.00519	CbGpPWpGaD
Carmustine—GSR—Metabolism—BCAN—malignant glioma	6.65e-05	0.00505	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	6.41e-05	0.00486	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	6.37e-05	0.00483	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	5.92e-05	0.0045	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN2A—malignant glioma	5.63e-05	0.00428	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	5.62e-05	0.00427	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MDM2—malignant glioma	5.47e-05	0.00415	CbGpPWpGaD
Carmustine—GSR—Metabolism—IDH2—malignant glioma	5.36e-05	0.00407	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CXCL8—malignant glioma	5.11e-05	0.00388	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP2B6—malignant glioma	5.04e-05	0.00383	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	4.93e-05	0.00374	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	4.68e-05	0.00355	CbGpPWpGaD
Carmustine—GSR—Metabolism—IDH1—malignant glioma	4.61e-05	0.0035	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	4.49e-05	0.00341	CbGpPWpGaD
Carmustine—GSR—Metabolism—SPHK1—malignant glioma	4.46e-05	0.00339	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP2C18—malignant glioma	4.37e-05	0.00332	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	4.35e-05	0.0033	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	4.25e-05	0.00323	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—VEGFA—malignant glioma	4.15e-05	0.00315	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—STAT3—malignant glioma	4.11e-05	0.00312	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	3.63e-05	0.00276	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	3.58e-05	0.00272	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTT1—malignant glioma	3.53e-05	0.00268	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTGS1—malignant glioma	3.31e-05	0.00252	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	3.15e-05	0.00239	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—TP53—malignant glioma	3.14e-05	0.00238	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	3.1e-05	0.00236	CbGpPWpGaD
Carmustine—GSR—Metabolism—BCHE—malignant glioma	3.08e-05	0.00234	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC5A5—malignant glioma	3.04e-05	0.00231	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	3.01e-05	0.00229	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	2.74e-05	0.00208	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	2.72e-05	0.00207	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	2.71e-05	0.00206	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	2.62e-05	0.00199	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTT1—malignant glioma	2.54e-05	0.00193	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	2.45e-05	0.00186	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTP1—malignant glioma	2.45e-05	0.00186	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	2.44e-05	0.00185	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	2.43e-05	0.00185	CbGpPWpGaD
Carmustine—GSR—Metabolism—CAT—malignant glioma	2.38e-05	0.00181	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—PTGS1—malignant glioma	2.38e-05	0.00181	CbGpPWpGaD
Carmustine—GSR—Metabolism—NCOR1—malignant glioma	2.25e-05	0.00171	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	2.07e-05	0.00157	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	1.9e-05	0.00144	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	1.86e-05	0.00141	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	1.86e-05	0.00141	CbGpPWpGaD
Carmustine—GSR—Metabolism—CAV1—malignant glioma	1.84e-05	0.00139	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—RTEL1—malignant glioma	1.78e-05	0.00135	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	1.77e-05	0.00135	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	1.77e-05	0.00135	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTP1—malignant glioma	1.76e-05	0.00134	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	1.76e-05	0.00133	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	1.74e-05	0.00132	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CG—malignant glioma	1.67e-05	0.00127	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPARG—malignant glioma	1.61e-05	0.00123	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CD—malignant glioma	1.47e-05	0.00112	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CB—malignant glioma	1.28e-05	0.000973	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	1.27e-05	0.000968	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTGS2—malignant glioma	1.27e-05	0.000964	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	1.23e-05	0.000936	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTEN—malignant glioma	1.11e-05	0.000841	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—COX8A—malignant glioma	1.02e-05	0.000778	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	9.15e-06	0.000695	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ASMT—malignant glioma	8.71e-06	0.000661	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	8.51e-06	0.000646	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—BCAN—malignant glioma	8.19e-06	0.000622	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CA—malignant glioma	7.81e-06	0.000593	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—IDH2—malignant glioma	6.6e-06	0.000501	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—malignant glioma	6.38e-06	0.000484	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.22e-06	0.000473	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2B6—malignant glioma	6.2e-06	0.000471	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—IDH1—malignant glioma	5.67e-06	0.000431	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SPHK1—malignant glioma	5.49e-06	0.000417	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2C18—malignant glioma	5.38e-06	0.000409	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.07e-06	0.000385	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.62e-06	0.000351	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.46e-06	0.000339	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTT1—malignant glioma	4.35e-06	0.00033	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS1—malignant glioma	4.08e-06	0.00031	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.06e-06	0.000308	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—BCHE—malignant glioma	3.79e-06	0.000288	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC5A5—malignant glioma	3.74e-06	0.000284	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.54e-06	0.000269	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.51e-06	0.000266	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.06e-06	0.000232	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTP1—malignant glioma	3.02e-06	0.000229	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CAT—malignant glioma	2.93e-06	0.000223	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOR1—malignant glioma	2.77e-06	0.00021	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CAV1—malignant glioma	2.26e-06	0.000172	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.16e-06	0.000164	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.06e-06	0.000156	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARG—malignant glioma	1.99e-06	0.000151	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.81e-06	0.000137	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.58e-06	0.00012	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.56e-06	0.000119	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTEN—malignant glioma	1.36e-06	0.000103	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CA—malignant glioma	9.61e-07	7.3e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—malignant glioma	7.85e-07	5.96e-05	CbGpPWpGaD
